Tilray: No End In Sight
Tilray continues to generate mounting losses.
The Canadian cannabis company faced extreme pricing pressure during Q3.
The risk that the company isn't EBITDA-positive in 2020 will pressure the stock next year with only $122 million in cash on hand.
Investors excited by the revenue headlines from the Q3 report for Tilray(TLRY) were hoodwinked into falling for the great Canadian cannabis disaster. These companies were built for massive growth and acquired additional global growth opportunities only to watch pricing collapse during this year of great growth following the approval of Canadian adult-use about a year ago. The $2.2 billion market cap remains far too expensive for their position in the market.
Read the full article on Seeking Alpha.
Disclosure: No position mentioned. Please review the disclaimer page for more details.